Viewing Study NCT02692664



Ignite Creation Date: 2024-05-06 @ 8:14 AM
Last Modification Date: 2024-10-26 @ 11:57 AM
Study NCT ID: NCT02692664
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-06-22
First Post: 2016-02-23

Brief Title: Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft
Sponsor: JOTEC GmbH
Organization: JOTEC GmbH

Study Overview

Official Title: Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2023-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TAILOR
Brief Summary: In this study patients will be observed who receive an E-liac Stent Graft for treatment of isolated iliac aneurysms or an E-liac Stent Graft in combination with one of the following AAA stent grafts E-tegra Stent Graft Endurant AAA Stent Graft Zenith AAA Endovascular Graft Gore Excluder AAA Endoprosthesis for treatment of aorto-iliac aneurysms

Objectives of this post-market registry are

Primary To prevent the risk of rupture and death by the treatment of common iliac aneurysm with an iliac branched stent graft E-liac JOTEC Secondary Evaluation of safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aorto-iliac or iliac aneurysm
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None